Brief: Conatus Pharmaceuticals Reports First Quarter 2020 Financial Results
01/05/2020 21:17
May 1 (Reuters) - Conatus Pharmaceuticals Inc CNAT.O :
* CONATUS PHARMACEUTICALS REPORTS FIRST QUARTER 2020
FINANCIAL
RESULTS AND STRATEGIC PROCESS UPDATE
* CONATUS PHARMACEUTICALS INC - DID NOT RECORD ANY REVENUE
FOR Q1
2020 VERSUS $7.0 MILLION IN Q1 2019
* CONATUS PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nGNX47jv70
Further company coverage: CNAT.O
((Briefs@thomsonreuters.com;))
Recent news on Histogen
See all newsBrief: Histogen Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Histogen Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Histogen Announces Board Approval Of Complete Liquidation And Dissolution
Histogen Inc expected to post a loss of 90 cents a share - Earnings Preview
Histogen to explore strategic options, shares up